Covid-19 Scenario:
- Non-urgent cancer treatments were postponed due to possibility of cross-contamination among cancer patients in the hospitals. Also, hospital staff was shifted to take care of increase in number of patients infected with coronavirus. This, in turn, reduced the number of staff members to take care of cancer patients.
- According to the paper published by the name “The impact of Covid-19 pandemic on quality of life in skin cancer patients,” non-melanoma cancer patients were at a higher risk of infection by the Covid-19 disease and needed special and rapid treatment. This, in turn, raised the need for diagnosis and demand for cutting-edge and innovative medicines to effectively treat patients.
According to the report published by Allied Market Research, The Skin Cancer Treatment Market Size was valued at USD 7.2 billion in 2021, and it is estimated to surpass around USD 14.5 billion by 2031, with a registered CAGR of 7.3% from 2022 to 2031.
Download Free Sample Report- https://www.alliedmarketresearch.com/request-sample/17975
Our Market Research Solution Provides You Answer to Below Mentioned Question:
• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in the coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2031?
• How big is the global & regional market in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• Which region has more opportunities?
Global Skin Cancer Treatment Market Segmentation –
The research provides detailed segmentation of the global skin cancer treatment market based on type, therapy, distribution channel, and region. The research discusses segments along with their sub-segments to identify the largest revenue-generating and fastest-growing segments for market players and startups. Market size and estimations for each segment and its sub-segment are offered in the report to identify the steps that can be adopted for achieving the growth.
Based on type, the melanoma segment held the highest share in 2021, accounting for more than four-fifths of the total share, and is projected to continue its leadership status during the forecast period. However, the non-melanoma segment is expected to manifest the highest CAGR of 8.8% from 2022 to 2031.
Based on distribution channel, the drug stores and retail pharmacies segment contributed to the highest share in 2021, holding nearly half of the market, and is expected to dominate in 2031. However, the online providers segment is projected to grow at the highest CAGR of 8.5% during the forecast period. The research also discusses the hospital pharmacies segments.
Based on therapy, the immunotherapy segment accounted for the highest share in 2021, contributing to more than three-fifths of the global skin cancer treatment market, and is projected to maintain its lead in terms of revenue during the forecast period. However, the targeted therapy segment is expected to manifest the highest CAGR of 8.6% from 2022 to 2031. The report also analyzes the chemotherapy segment.
Based on region, North America accounted for the highest share in 2021, holding more than two-fifths of the global market, and is expected to maintain its dominance by 2031. However, Asia-Pacific is estimated to grow at the fastest CAGR of 8.6% during the forecast period. The research also analyzes regions including Europe and LAMEA.
Skin Cancer Treatment Companies –
• Amgen Inc.
• Bristol Myers Squibb Company
• F.Hoffman –La-Roche Ltd.
• GlaxoSmithKline Plc.
• LEO Pharm A/S
• Novartis AG
• Merck KGAA
• Regeneron Pharmaceuticals
• Pfizer Inc.
• Sun Pharmaceuticals Industries Ltd
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/17975
By Region Outlook
North America
⦁ U.S.
⦁ Canada
⦁ Mexico
Europe
⦁ UK
⦁ Germany
⦁ France
⦁ Italy
⦁ Russia
⦁ Rest of Europe
Asia-Pacific
⦁ China
⦁ Japan
⦁ India
⦁ Australia
⦁ Rest of Asia-Pacific
LAMEA
⦁ Brazil
⦁ UAE
⦁ Turkey
⦁ Saudi Arabia
⦁ Rest of LAMEA
Have Any Query? Ask Our Experts: https://www.alliedmarketresearch.com/connect-to-analyst/17975
Other Trending Report:
- Healthcare IT Market
- Rheumatoid Arthritis Drugs Market
- Allergy Diagnostics Market
- Medical Device Affairs Outsourcing Market
- Medical Tape market
Contact Details:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.